Preserving and consolidating biomedical databases – Human Technopole signs MoU with the Department of Biology of the University of Rome “Tor Vergata”
Milan, 1 April – Human Technopole and the Department of Biology of the University of Rome “Tor Vergata” have signed an MoU that demonstrates their joint commitment towards the continued development of two databases, MINT and SIGNOR, which over time have become fundamental resources for the European bioinformatics community.
Around 20 years ago the Molecular Genetics Group in Tor Vergata, led by Prof. Cesareni, initiated the development of two data resources, the Molecular INTeraction (MINT) and, more recently, the SIGnalling Network Open Resource (SIGNOR) databases, aimed at capturing literature information about physical and functional molecular interactions respectively.
Discussions between Human Technopole and the Department of Biology of “Tor Vergata” have been ongoing since 2019 in an effort to ensure the continuity of the two databases, which require the work of expert staff who mine and annotate information from scientific literature. Scientists from all over the world can access the databases in the spirit of openness that characterises scientific research.
Over time, MINT has become increasingly important within the scientific community and is now part of the ELIXIR network, the intergovernmental organisation that brings together life science resources from across Europe. It is currently the only Italian data resource to be included among the ELIXIR Core Data Resources.
The cooperation between the two organisations towards the continued development of the MINT and SIGNOR datasets is envisioned to take different shapes, and to be pursued through the work of dedicated informaticians and curators. A further agreement will regulate specific aspects of the collaboration, including the future governance structure and policy on the use of the MINT and SIGNOR databases to benefit the wider research community and thus facilitating new breakthroughs in biomedicine.
“The close interaction between the databases developed by the Department of Biology in Tor Vergata and the Human Technopole projects will ensure the continuity of these important biological resources while at the same time contributing to advance the Human Technopole mission of linking genetic data to disease phenotypes” comments Prof. Cesareni.
The data sets. MINT is an established resource that is a founding member of the international iMEX consortium of federated databases. The iMEX consortium aims at coordinating the capture – in a structured and easily accessible format – of information on experimentally verified protein-protein interactions. Whereas the more recent SIGNOR, using a similar approach, specifically focusses on causal relationships (i.e. functional interactions) between proteins and other biological entities involved in signal transduction. The MoU also involves collaborative work on two ancillary disease-focussed resources, DISNOR (for genetic diseases) and CancerGeneNet (for cancers) that have been developed to support genetic data interpretation and personalised medicine. DISNOR in particular combines the causal interaction information annotated in SIGNOR with protein interaction data to generate and explore disease pathways. CancerGeneNet aims at connecting genes that are frequently mutated in cancers to cancer phenotypes, thereby linking driver genes to cancer hallmarks.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.